Ross Moat - CHIEF COMMERCIAL OFFICER at Kiniksa Pharmaceuticals International, plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Officer
Stock Symbol
KNSA on Nasdaq
All Insider Reports
All Insider Reports

Ross Moat - trading volume in the past year for Kiniksa Pharmaceuticals International, plc

Holdings reported by Ross Moat for Kiniksa Pharmaceuticals International, plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Ordinary Share 21.7K $589K $27.12 Sep 3, 2024 Direct
Class A Common Share 16.3K $291K $17.90 Apr 8, 2024 Direct
Performance Share Unit 5.57K $99.7K $17.90 Apr 4, 2024 Direct Class A Common Share
Share Option 30.9K Sep 3, 2024 Direct Class A Ordinary Share
Restricted Share Unit 9.32K Apr 8, 2024 Direct Class A Common Share
Restricted Share Unit 994 Sep 2, 2024 Direct Class A Ordinary Share

Transactions reported by Ross Moat for Kiniksa Pharmaceuticals International, plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.